RETRACTION: LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis (Retraction of Vol 13, Pg 7543, 2021)

被引：0
|
作者：
不详
机构：
来源：
CANCER MANAGEMENT AND RESEARCH | 2023年 / 15卷
关键词：
D O I：
10.2147/CMAR.S438016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：979 / 979
页数：1
相关论文
共 27 条
  • [1] RETRACTED: LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis (Retracted Article)
    Li, Yu
    Wang, Liqin
    Xu, Xiaoyi
    Sun, Heng
    Wu, Leilei
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7543 - 7557
  • [2] RETRACTION: LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis (Retraction of Vol 13, Pg 9037, 2021)
    Li, Z.
    Li, M.
    Xia, P.
    Wang, L.
    Lu, Z.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 257 - 257
  • [3] RETRACTION: LncRNA HCG11 regulates proliferation and apoptosis of vascular smooth muscle cell through targeting miR-144-3p/FOXF1 axis in atherosclerosis (Retraction of Vol 53, art no 44, 2020)
    Liu, Yi
    Cui, Xiyun
    Wang, Cong
    Zhao, Sihai
    BIOLOGICAL RESEARCH, 2021, 54 (01)
  • [4] RETRACTION: lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis (Retraction of Vol 13, Pg 9225, 2020)
    Gao, J.
    Chen, Q.
    Zhao, Y.
    Hou, R.
    ONCOTARGETS AND THERAPY, 2020, 13 : 12721 - 12721
  • [5] RETRACTION: Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis (Retraction of Vol 13, Pg 2717, 2021)
    Zhang, W.
    Wang, Z.
    Cai, G.
    Huang, P.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 1005 - 1005
  • [6] RETRACTION: LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis (Retraction of Vol 16, Pg 733, 2013)
    Bi, H.
    Shang, Z.
    Jia, C.
    ONCOTARGETS AND THERAPY, 2022, 15 : 681 - 681
  • [7] RETRACTION: lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis (Retraction of Vol 13, Pg 4523, 2020)
    Wei, P.
    Yang, J.
    Zhang, D.
    Cui, M.
    Li, L.
    ONCOTARGETS AND THERAPY, 2022, 15 : 133 - 133
  • [8] RETRACTION: Long Chain Non- Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1 (Retraction of Vol 25, Pg 1537, 2019)
    Jiang, Datong
    Li, He
    Xiang, Heping
    Gao, Ming
    Yin, Chunlin
    Wang, Haiping
    Sun, Yuansong
    Xiong, Maoming
    MEDICAL SCIENCE MONITOR, 2023, 29 : e939464
  • [9] RETRACTION: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retraction of Vol 12, Pg 9999, 2020)
    Wang, Y.
    Wang, X.
    Han, L.
    Hu, D.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3457 - 3457
  • [10] RETRACTION: The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells (Retraction of Vol 35, Pg 204, 2018)
    Guo, Jiwei
    Jin, Dan
    Wu, Yan
    Yang, Lijuan
    Du, Jing
    Gong, Kaikai
    Chen, Weiwei
    Dai, Juanjuan
    Miao, Shuang
    Xi, Sichuan
    EBIOMEDICINE, 2021, 63
123